Patel, A., Parekh, D., Desai, D., Patel, V., Shah, V., Prajapati, K., Patel, S. C., Seth, R. (2026). Sequencing in the post-immunotherapy era: Does second-line tyrosine kinase inhibitor choice impact survival and safety in advanced HCC?. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4140